Table 3. Immunohistochemical results of CA9 expression in patients with primary OTSCC.
Characteristic | Subtype | No. of cases [%] | CA9 expression | P value | |
---|---|---|---|---|---|
Low | High | ||||
Age (years) | <60 | 27 [54] | 11 | 16 | 0.742 |
≥60 | 23 [46] | 10 | 13 | ||
Sex | Male | 32 [64] | 13 | 19 | 0.822 |
Female | 18 [36] | 8 | 10 | ||
Differentiation | Well | 31 [62] | 15 | 16 | 0.495 |
Moderate | 12 [24] | 4 | 8 | ||
Poor | 7 [14] | 2 | 5 | ||
Pathologic N-stage | N0 | 39 [78] | 18 | 21 | 0.262 |
N1 + N2 | 11 [22] | 3 | 8 | ||
Pathologic T-stage | T1 + T2 | 41 [82] | 20 | 21 | 0.038* |
T3 + T4 | 9 [18] | 1 | 8 | ||
Stage | I + II | 30 [60] | 16 | 14 | 0.047* |
III + IV | 20 [40] | 5 | 15 |
*, P value <0.05. CA9, carbonic anhydrase 9; OTSCC, oral tongue squamous cell carcinoma.